Systemic lupus erythematosus with disease onset at 65 and older

被引:10
作者
Gaujard, S
Broussolle, C
Cathebras, P
Dupond, JL
Massot, C
Ninet, J
Perrot, H
Durand, DV
Rousset, H
机构
[1] CHU Lyon, Hop Geriat Antoine Charial, F-69340 Francheville, France
[2] Hop Hotel Dieu, Serv Med Interne, F-69288 Lyon 02, France
[3] CHU St Etienne, Serv Med Interne, F-42055 St Etienne 2, France
[4] Hop Jean Minjoz, Serv Med Interne, F-25030 Besancon, France
[5] CHU Grenoble, Serv Med Interne, F-38043 Grenoble 09, France
[6] Hop Edouard Herriot, Serv Med Interne, F-69437 Lyon 03, France
[7] Hop Antiquaille, Serv Dermatol, F-69321 Lyon 05, France
[8] Ctr Hosp Lyon Sud, Serv Med Interne, F-69495 Pierre Benite, France
来源
REVUE DE MEDECINE INTERNE | 2003年 / 24卷 / 05期
关键词
lupus erythematosus; systemic; autoimmune diseases; aged;
D O I
10.1016/S0248-8663(03)00052-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. - Systemic lupus erythematosus with disease-onset in the elderly has rarely been studied (only one report about 21 patients with disease onset at 65 and older). Is the management of this pathology modified in this population? Methods. - Seventeen hospitalised cases of lupus patients with disease onset at 65 or older are retrospectively reported between 1988 and 2000. The results are compared with those of younger subjects. Results. - The female to male ratio is 1.83. Mean age at disease onset is 71.9 +/- 3.5 years. Mean duration of follow-up is 3.5 +/- 2.4 years. Main initial symptoms are: deterioration of general status (41%), arthritis (35%), cutaneous manifestations (35%), thrombo-embolism (24%) and pleuritis (18%). Malar rash is uncommon (12%). Nephropathy is never a revealing symptom and is rarely serious during the disease's evolution. Like in neurologic manifestations, the etiology has to be discussed in relation to associated co-morbidities. Concerning haematologic features, lymphopenia is found in 82% of the cases with a questionable specificity. Antinuclear antibodies are constant, anti-dsDNA antibodies are found in 82% of the cases, antibodies to extractable nuclear antigens in 50%, and anticoagulant circulating activity in 59%. Prognosis is difficult to assess in such a limited series but 5-years survival probability is 83%. Glucocorticoid lead to 50% of major complications. Conclusions. - This study focuses on the particular initial manifestations of systemic lupus erythematosus in the elderly (deterioration of general status, thrombosis, unusual cutaneous symptoms), and on the specificity of differential diagnosis and treatment. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 34 条
  • [1] OCCULT SYSTEMIC LUPUS-ERYTHEMATOSUS IN ELDERLY MEN
    BAER, AN
    PINCUS, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (24): : 3350 - 3352
  • [2] BELL DA, 1988, J RHEUMATOL, V15, P723
  • [3] Myelodysplastic syndromes and systemic manifestations. A non-casual association.
    Berthier, S
    Magy, N
    Gil, H
    Schneider, MB
    Vuitton, DA
    Dupond, JL
    [J]. REVUE DE MEDECINE INTERNE, 2001, 22 (05): : 428 - 432
  • [4] Prevalence of organ-specific and non organ-specific autoantibodies in healthy centenarians
    Candore, G
    DiLorenzo, G
    Mansueto, P
    Melluso, M
    Frada, G
    LiVecchi, M
    Pellitteri, ME
    Drago, A
    DiSalvo, A
    Caruso, C
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 1997, 94 (1-3) : 183 - 190
  • [5] SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND IMMUNOLOGICAL PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS
    CERVERA, R
    KHAMASHTA, MA
    FONT, J
    SEBASTIANI, GD
    GIL, A
    LAVILLA, P
    DOMENECH, I
    AYDINTUG, AO
    JEDRYKAGORAL, A
    DERAMON, E
    GALEAZZI, M
    HAGA, HJ
    MATHIEU, A
    HOUSSIAU, F
    INGELMO, M
    HUGHES, GRV
    CERVERA, R
    SEBASTIANI, GD
    FONT, J
    KHAMASHTA, MA
    HUGHES, GRV
    FONT, J
    CERVERA, R
    LOPEZSOTO, A
    VIVANCOS, J
    INGELMO, M
    URBANOMARQUEZ, A
    KHAMASHTA, MA
    VIANNA, J
    HUGHES, GRV
    GIL, A
    LAVILLA, P
    PINTADO, V
    LOPEZDUPLA, M
    VAZQUEZ, JJ
    SEBASTIANI, GD
    DERAMON, E
    CAMPS, M
    FRUTOS, MA
    PERELLO, I
    SANTOS, PG
    ABARCA, M
    NEBRO, AF
    DOMENECH, I
    TOKGOZ, G
    AYDINTUG, AO
    JEDRYKAGORAL, A
    MALDYKOWA, H
    CHWALINSKASADOWSKA, H
    GALEAZZI, M
    [J]. MEDICINE, 1993, 72 (02) : 113 - 124
  • [6] COSTALLAT LTL, 1994, CLIN EXP RHEUMATOL, V12, P603
  • [7] NEUROPSYCHIATRIC SYSTEMIC LUPUS-ERYTHEMATOSUS IN ELDERLY PEOPLE - A CASE SERIES
    DENNIS, MS
    BYRNE, EJ
    HOPKINSON, N
    BENDALL, P
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (12) : 1157 - 1161
  • [8] DUBOIS EL, 1964, JAMA-J AM MED ASSOC, V190, P104
  • [9] SYSTEMIC LUPUS-ERYTHEMATOSUS IN THE ELDERLY - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS
    FONT, J
    PALLARES, L
    CERVERA, R
    LOPEZSOTO, A
    NAVARRO, M
    BOSCH, X
    INGELMO, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (10) : 702 - 705
  • [10] Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI
    Formiga, F
    Moga, I
    Pac, M
    Mitjavila, F
    Rivera, A
    Pujol, R
    [J]. LUPUS, 1999, 8 (06) : 462 - 465